Cite
HARVARD Citation
Prather, C. et al. (2020). Romosozumab: A first-in-class sclerostin inhibitor for osteoporosis. American journal of health-system pharmacy. pp. 1949-1956. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Prather, C. et al. (2020). Romosozumab: A first-in-class sclerostin inhibitor for osteoporosis. American journal of health-system pharmacy. pp. 1949-1956. [Online].